Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus

Les Gommons, créatures massives aux yeux vitreux, aux cheveux d’algue et à la peau couverte d’écailles visqueuses, ressemblaient à des hommes par leur allure, mais plutôt à

Cette étude avait pour objectif de comparer le profil pharmacocinétique et pharmacodynamique de l’insuline glargine 300 U/ ml (Gla-300) avec celui de l’insuline dégludec 100

Randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.. Shah BR, Hux JE, Laupacis

The primary focus of this phenomenological study was to understand the lived experience of adults with a Continuous Subcutaneous Insulin Infusion (CSII) device, better known as an

This study evaluates the association between an indirect measure of insulin resistance and diabetic macular edema in type 2 diabetes mellitus patients, specifically the cystic

For eligible patients, the following data were collected from their medical charts: demographic data (i.e., age, sex); dura- tion of diabetes; stage of diabetic

Le livre d'Albert Carozzi vient donc à point nommé, à peine plus de deux siècles après la disparition d' Horace- Bénédict de Saussure , pour restituer la riche personnalité de

Compared with first-generation basal insulin analogues, second- generation treatments (insulin glargine 300 U/mL [Gla-300] and insulin degludec [IDeg]) have demonstrated